Cargando…
Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma
Lambert-Eaton myasthenic syndrome (LEMS) is a rare, autoimmune or paraneoplastic condition characterized by muscle weakness and fatigability. In cancer therapy, immune checkpoint inhibitors (ICI) sensitize the immune system for tumor antigens. We report a 62-year-old, female patient with paraneoplas...
Autores principales: | Dohrn, Maike F., Schöne, Ulrike, Küppers, Charlotte, Christen, Deborah, Schulz, Jörg B., Gess, Burkhard, Tauber, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727206/ https://www.ncbi.nlm.nih.gov/pubmed/33324947 http://dx.doi.org/10.1186/s42466-020-00099-5 |
Ejemplares similares
-
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies
por: Wada, Shinichi, et al.
Publicado: (2020) -
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report
por: AGOSTINI, Andrea, et al.
Publicado: (2021) -
Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx
por: Takasugi, Junji, et al.
Publicado: (2017) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022)